Gavilax Powder, For Solution
Product Images NDC 43386-312

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gavilax (NDC 43386-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84e2d8a7 B967 4df5 A784 6a7b129dbe32 01

GaviLAX 17 g powder for oral solution, polyethylene glycol 3350 osmotic laxative from Lupin Pharmaceuticals, Inc. The label states it relieves occasional constipation and softens stool. It contains 7 once-daily doses with a net weight of 4.1 oz (119 g). The label also includes usage warnings and drug facts on the side.*

FDA Label Image

84e2d8a7 B967 4df5 A784 6a7b129dbe32 02

Drug Facts panel from the GAVILAX (Polyethylene Glycol 3350) powder for solution label provides usage directions, warnings about overdose and use in children, storage instructions, tamper-evidence information, and indicates no inactive ingredients. Contact information for questions or comments is also included.*

FDA Label Image

84e2d8a7 B967 4df5 A784 6a7b129dbe32 03

Label for GaviLAX 17 g powder for oral solution, an osmotic laxative with active ingredient Polyethylene Glycol 3350. The label states product strength as 17 grams per dose, indicates it relieves occasional constipation and softens stool, and provides directions, warnings, and other drug facts. The label is from Lupin Pharmaceuticals, Inc. and includes a comparison to MiraLAX.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.